Effectiveness of Pfizer-BioNTech (BNT162b2) Vaccine Among Adolescents (Aged 12-15 Years): An Observational Study in Qatar.
Saved in:
| Title: | Effectiveness of Pfizer-BioNTech (BNT162b2) Vaccine Among Adolescents (Aged 12-15 Years): An Observational Study in Qatar. |
|---|---|
| Authors: | Azeez MA; Al Waab Health Center, Primary Health Care Corporation, Doha, Qatar.; Weill Cornell Medicine, Doha, Qatar.; School of Medicine, Qatar University, Doha, Qatar.; Faculty of Medicine, Qatar University, Doha, Qatar., Hussain MS; Abu Nakhla Health Center, Primary Health Care Corporation, Doha, Qatar., Veettil ST; Department of Clinical Research, Primary Health Care Corporation, Doha, Qatar., Al Mesallam MS; Al Waab Health Center, Primary Health Care Corporation, Doha, Qatar., Muhammed AC; Al Waab Health Center, Primary Health Care Corporation, Doha, Qatar., Abdulmajeed J; Strategy Planning & Health Intelligence-Business & Health Intelligence Department, Primary Health Care Corporation, Doha, Qatar., Krishnan JI; Strategy Planning & Health Intelligence-Business & Health Intelligence Department, Primary Health Care Corporation, Doha, Qatar. |
| Source: | Clinical pediatrics [Clin Pediatr (Phila)] 2024 Jan; Vol. 63 (1), pp. 89-95. Date of Electronic Publication: 2023 Nov 22. |
| Publication Type: | Observational Study; Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 0372606 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-2707 (Electronic) Linking ISSN: 00099228 NLM ISO Abbreviation: Clin Pediatr (Phila) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
